[Recent advances in neuroblastoma research].
Imaizumi
Masue
M
Department of Hematology and Oncology, Miyagi Children's Hospital, 4-3-17 Ochiai, Aoba-ku, Sendai 989-3126, Japan.
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D051792:Basic Helix-Loop-Helix Proteins; D019485:Bone Morphogenetic Proteins / Q000502:physiology; D002454:Cell Differentiation / Q000235:genetics; D002878:Chromosomes, Human, Pair 1 / Q000235:genetics; D003131:Combined Modality Therapy; D004268:DNA-Binding Proteins / Q000502:physiology; D004171:Diploidy; D017313:Fenretinide / Q000627:therapeutic use; D005732:Gangliosides / Q000276:immunology; D006801:Humans; D007223:Infant; D019656:Loss of Heterozygosity; D000071447:N-Myc Proto-Oncogene Protein; D009447:Neuroblastoma / Q000235:genetics / Q000628:therapy; D009687:Nuclear Proteins / Q000235:genetics; D015513:Oncogene Proteins / Q000235:genetics; D020794:Receptor Protein-Tyrosine Kinases / Q000502:physiology; D013564:Sympathetic Nervous System / Q000166:cytology / Q000196:embryology; D014157:Transcription Factors / Q000502:physiology; D014212:Tretinoin / Q000627:therapeutic use
D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D051792:Basic Helix-Loop-Helix Proteins; D019485:Bone Morphogenetic Proteins; D004268:DNA-Binding Proteins; D017313:Fenretinide; D005732:Gangliosides; D000071447:N-Myc Proto-Oncogene Protein; D009687:Nuclear Proteins; D015513:Oncogene Proteins; D020794:Receptor Protein-Tyrosine Kinases; D014157:Transcription Factors; D014212:Tretinoin; C065500:ASCL1 protein, human; C459801:MYCN protein, human; C025447:sialogangliosides